<p>Correlations among cerebrospinal fluid (CSF) α-syn (α-synuclein), amyloid beta 1–42 (Aβ<sub>1–42</sub>), total tau (t-tau) and phosphorylated tau 181P (p-tau) in Parkinson disease (PD) participants evaluated at baseline (n = 409). A significant positive correlation was found between CSF levels of α-syn and Aβ <sub>1–42</sub> (A), and tau (B). Because interpretation of α-syn might be confounded by blood contamination of CSF samples, 78 subjects with Hgb levels above the 200 ng/ml were excluded from α-syn analysis. Lines indicate trends within each group as determined by linear regression.</p
Relevance of blood-based biomarkers is increasing into the neurodegenerative diseases field, but da...
Identifying biomarkers that distinguish Parkinson's disease (PD) from normal control (NC) individual...
Objective Cerebrospinal fluid (CSF) biomarkers, such as alpha-synuclein (alpha-syn), amyloid beta ...
ImportanceWe observed a significant correlation between cerebrospinal fluid (CSF) levels of tau prot...
Purpose To investigate the relationships among cerebrospinal fluid (CSF) levels of t-Tau, p-Tau and ...
Purpose To investigate the relationships among cerebrospinal fluid (CSF) levels of t-Tau, p-Tau and ...
Importance: We observed a significant correlation between cerebrospinal fluid (CSF) levels of tau pr...
Purpose To investigate the relationships among cerebrospinal fluid (CSF) levels of t-Tau, p-Tau and ...
Purpose To investigate the relationships among cerebrospinal fluid (CSF) levels of t-Tau, p-Tau and ...
Purpose To investigate the relationships among cerebrospinal fluid (CSF) levels of t-Tau, p-Tau and ...
There is a great interest in developing cerebrospinal fluid (CSF) biomarkers for diagnosis and progn...
The development of biomarkers to predict the progression of Parkinson's disease (PD) from its earlie...
Cerebrospinal fluid (CSF) biomarkers, such as α-synuclein (α-syn), amyloid beta peptide 1-42 (Aβ1-42...
Relevance of blood-based biomarkers is increasing into the neurodegenerative diseases field, but da...
Relevance of blood-based biomarkers is increasing into the neurodegenerative diseases field, but da...
Relevance of blood-based biomarkers is increasing into the neurodegenerative diseases field, but da...
Identifying biomarkers that distinguish Parkinson's disease (PD) from normal control (NC) individual...
Objective Cerebrospinal fluid (CSF) biomarkers, such as alpha-synuclein (alpha-syn), amyloid beta ...
ImportanceWe observed a significant correlation between cerebrospinal fluid (CSF) levels of tau prot...
Purpose To investigate the relationships among cerebrospinal fluid (CSF) levels of t-Tau, p-Tau and ...
Purpose To investigate the relationships among cerebrospinal fluid (CSF) levels of t-Tau, p-Tau and ...
Importance: We observed a significant correlation between cerebrospinal fluid (CSF) levels of tau pr...
Purpose To investigate the relationships among cerebrospinal fluid (CSF) levels of t-Tau, p-Tau and ...
Purpose To investigate the relationships among cerebrospinal fluid (CSF) levels of t-Tau, p-Tau and ...
Purpose To investigate the relationships among cerebrospinal fluid (CSF) levels of t-Tau, p-Tau and ...
There is a great interest in developing cerebrospinal fluid (CSF) biomarkers for diagnosis and progn...
The development of biomarkers to predict the progression of Parkinson's disease (PD) from its earlie...
Cerebrospinal fluid (CSF) biomarkers, such as α-synuclein (α-syn), amyloid beta peptide 1-42 (Aβ1-42...
Relevance of blood-based biomarkers is increasing into the neurodegenerative diseases field, but da...
Relevance of blood-based biomarkers is increasing into the neurodegenerative diseases field, but da...
Relevance of blood-based biomarkers is increasing into the neurodegenerative diseases field, but da...
Identifying biomarkers that distinguish Parkinson's disease (PD) from normal control (NC) individual...
Objective Cerebrospinal fluid (CSF) biomarkers, such as alpha-synuclein (alpha-syn), amyloid beta ...